As we begin to reopen Rush University Medical Center for elective procedures and in-person care, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.

Excellence is just the beginning.


French German Italian Portuguese Russian

Stroke Program — Clinical Trials

Amplatzer™ Post Approval Study

Amplatzer™ Post approval study.

ARAMIS Registry: Addressing Anticoagulant Management Issues in Stroke

ARAMIS Registry: Addressing anticoagulant management issues in stroke.

ENRICH Trial: Comparison Study in the Treatment of Intracerebral Hemorrhage

ENRICH: A multi-center, randomized, clinical trial comparing standard medical management to early surgical hematoma evacuation using minimally invasive parafascicular surgery (MIPS) in the treatment of intracerebral hemorrhage (ICH).

MyRIAD Study

MyRIAD study.

Prevention of Stroke Recurrence in Patients with Embolic Stroke Study

Randomized evaluation in secondary stroke prevention comparing dabigatran extexilate versus aspirin in embolic stroke of undetermined source.


PRISMS: A phase IIIb, double-blind, multicenter study to evaluate the efficacy and safety of alteplase in patients with mild stroke, rapidly improving symptoms and minor neurological deficits

Spontaneous Intracerebral Hemorrhage and Diffusion Weighted Imaging

The effect of diffusion weighted imaging (DWI) abnormalities on outcomes in patients with spontaneous intracerebral hemorrhage.

Study of Intravenous Thrombolysis Related Coagulopathy in Acute Ischemic Stroke

Prospective study on intravenous thrombolysis related coagulopathy in acute ischemic stroke.

Transient Ischemic Attack Study (POINT)

Platelet-oriented inhibition in new TIA (POINT)